Scilex Holding Co (SCLX) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$5.36

From 52W high−83.20%

Volume26995.00

Market cap$42.80M

P/E (TTM)—

P/S (TTM)1.4x

Div yield—

Key dataSep 18, 2026

Open

$5.36

From 52W high

−83.20%

Volume

26995.00

Market cap

$42.80M

ValuationView details →

P/E (Fwd)

54.0x

EV/EBITDA

−0.4x

P/E (TTM)

—

RSI (14)

40.1

MomentumView details →

1D Return

−6.15%

YTD Return

−57.10%

SummaryUpdated Jun 1, 2026

Scilex Holding Company (NASDAQ:SCLX) is a biopharmaceutical company founded in 2016 and publicly traded since March 2021. Based in Palo Alto, California, the company operates as a subsidiary of Sorrento Therapeutics and focuses on developing and commercializing non-opioid pain management solutions. Scilex addresses the critical healthcare challenge of treating acute and chronic pain without contributing to the opioid crisis that has plagued the United States for decades.

Ask drillr about Scilex Holding Co →

ValuationView details →

P/E (Fwd)

54.0x

P/E (TTM)

—

EV/EBITDA

−0.4x

EV/Sales

4.3x

P/S (TTM)

1.4x

P/B (TTM)

−0.1x

ProfitabilityView details →

Gross Margin

41.49%

Net Margin

−1414.57%

EBITDA Margin

−1140.84%

ROE (TTM)

145.02%

ROA (TTM)

−176.33%

Asset Turnover

0.12x

GrowthView details →

Revenue YoY

−28.55%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−7.35%

EPS CAGR 3Y

−87.75%

EBITDA YoY

—

MomentumView details →

1D Return

−6.15%

YTD Return

−57.10%

1Y Return

−82.00%

RSI (14)

40.1

vs 50D SMA

−18.99%

vs 200D SMA

−37.28%

Capital & dividendView details →

Debt/Equity

−0.31x

Current Ratio

0.07x

Quick Ratio

0.06x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$16.65

EPS Surprise

−9083.17%

Beats (12Q)

0/12

Next Q EPS Est

−$0.08

Avg Surprise (4Q)

−4180.29%

Rev Surprise

−52.24%

Financials snapshotView financials →

Revenue (TTM)

31.61M

Net Income (TTM)

−447.12M

Op. CF (TTM)

−17.49M

Next earningsDec 2, 2026 →

Latest newsMore news →

Scilex loan was substantially repaid to Oramed Pharmaceuticals.87d ago

Similar companies

MIRA Pharmaceuticals, Inc.MIRA Citius Oncology, Inc.CTOR Bristol-Myers Squibb Company CeCELG-RI Modern Chinese Medicine Group Co., Ltd.01643.HK Beijing Biostar Pharms Co Ltd02563.HK Fangzhou Inc.06086.HK Find similar companies →

Latest newsMore news →

DataMeds AI announced the pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings and HealthBridge Associates to consolidate intellectual properties and deliver the 'Health Lives Here' consumer app in partnership with NFL Alumni Health.34d ago Scilex loan was substantially repaid to Oramed Pharmaceuticals.87d ago Scilex Holding Company set June 15, 2026 as the payment date for its previously announced dividend of Semnur Pharmaceuticals common stock to holders of Scilex common stock and other eligible equity securities.108d ago